Filing Flows › Lantheus Holdings (LNTH) › Q3 2026 › vs Q3 2025
Lantheus Holdings (LNTH) Q3 2026 vs Q3 2025 (year over year)
Lantheus Holdings's revenue rose $5.9M (+2%) from $384M in Q3 2025 to $390M in Q3 2026. The biggest changes: Neuraceq +$25.1M (+123%); Strategic Partnerships and Other +$6.0M (+44%); Definity +$3.9M (+5%). Gross margin 62.4% against 57.9% (+4.5 pts).
Lantheus Holdings, Q3 2026: revenue $390M (+2% year over year), operating margin 8.3%, net earnings $22.4M, operating cash flow $102M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 62.4% | 57.9% | +4.5 pts |
| Operating margin | 8.3% | 11.4% | -3.1 pts |
| Net margin | 5.7% | 7.2% | -1.5 pts |
| Free cash flow margin | 25.6% | 24.7% | +1.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| PYLARIFY | $239M | $241M | −$1.7M | -0.7% |
| Definity | $85.7M | $81.8M | $3.9M | +5% |
| Neuraceq | $45.6M | $20.4M | $25.1M | +123% |
| Strategic Partnerships and Other | $19.7M | $13.7M | $6.0M | +44% |
| Revenue | $390M | $384M | $5.9M | +2% |
| Gross profit | $243M | $222M | $21.0M | +9% |
| Cost of revenue | $147M | $162M | −$15.1M | -9% |
| Operating profit | $32.2M | $43.6M | −$11.4M | -26% |
| Operating expenses | $211M | $179M | $32.5M | +18% |
| Pre-tax earnings | $21.8M | $42.4M | −$20.6M | -49% |
| Other expense, net | $10.4M | $1.2M | $9.2M | +745% |
| Research & development | $92.8M | $48.0M | $44.7M | +93% |
| Sales & marketing | $48.1M | $48.8M | −$769K | -2% |
| General & admin | $70.4M | $81.9M | −$11.5M | -14% |
| Income tax benefit | $594K | −$14.6M | $15.2M | — |
| Net earnings | $22.4M | $27.8M | −$5.4M | -19% |
| Depreciation & amortization | $22.9M | $20.4M | $2.5M | +12% |
| Share-based compensation | $21.9M | $24.5M | −$2.6M | -11% |
| Working capital & other | $34.8M | $32.6M | $2.2M | +7% |
| Operating cash flow | $102M | $105M | −$3.3M | -3% |
| Free cash flow (company-reported) | $99.9M | $94.7M | $5.3M | +6% |
| Capital expenditures | $2.0M | $10.6M | −$8.6M | -81% |
Questions
How much did Lantheus Holdings's revenue grow year over year in Q3 2026?
Lantheus Holdings's revenue rose $5.9M (+2%) from $384M in Q3 2025 to $390M in Q3 2026.
What drove Lantheus Holdings's revenue change in Q3 2026?
Neuraceq +$25.1M (+123%); Strategic Partnerships and Other +$6.0M (+44%); Definity +$3.9M (+5%).